New patent for Gilead Sciences drug SUNLENCABy DrugPatentWatch – Make Better Decisions / April 25, 2024 Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four…Source